WebApr 26, 2024 · Subsequently, the newly installed board appointed Dr. Paul Stoffels* as chairman of the board. Galapagos held its Extraordinary General Meeting (EGM) and … WebGalapagos and NovAliX enter into an integrated drug discovery collaboration. Press release. Company news. 2024 Annual Report. Our 2024 Annual Report is online! ... Paul … (thousands of €, if not stated otherwise) Year ended 31 December 2024: Year … Press Releases - Galapagos - homepage - GLPG Galapagos and Gilead have been collaborating since 2015 on the … Stock Charts - Galapagos - homepage - GLPG Galapagos is a fully integrated biotechnology company focused on … Webcasts - Galapagos - homepage - GLPG Galapagos SASU 102 Avenue Gaston Roussel 93230 Romainville, France Tel: … At Galapagos, we also organize clinical trials for investigational treatments in … At Galapagos, we are united around a single purpose: to transform patient … Upcoming events. Galapagos regularly takes part in investor conferences. We …
Paul Stoffels, MD LinkedIn
WebMay 6, 2024 · Galapagos NV (NASDAQ:NASDAQ:GLPG) Q1 2024 Results Conference Call May 6, 2024 8:00 AM ETCompany ParticipantsSofie Van Gijsel - Senior Director, Investor RelationsPaul Stoffels - Chief... WebJan 27, 2024 · Paul Stoffels, the former chief scientific officer of Johnson & Johnson, will take over as CEO of the Belgium-based drugmaker Galapagos, as the once high-flying … joggers for men with shirts
Galapagos appoints Paul Stoffels as Chief Executive Officer
WebNov 4, 2024 · When long-serving Johnson & Johnson R&D chief Paul Stoffels cut short his retirement to take the helm at Galapagos earlier this year, it was clear he faced a challenge to steer the troubled Belgian biotech back on course.. Several months later, and Stoffels (pictured above) has charted the way ahead under a new strategy he calls ‘forward, … WebMay 9, 2024 · Executive Summary. Pharma veteran Paul Stoffels, the new CEO of Galapagos, is not thinking about using the Belgian biotech’s cash pile to buy Phase III drugs but is open to licensing deals with US firms who have drugs approved at home and are looking for a European partner. WebGalapagos’ new CEO, Paul Stoffels, M.D., is ready to jump into acquisition and partnership talks and review new chief science officer candidates as he oversees a much-needed turnaround for the 23-year-old biotech. The Gilead-partnered company has a “very strong foundation with a significant balance sheet, which allows [us] to start going ... joggers for men with shoes